Cardiovascular disease screening

Area of Science:

• Cardiology
• Obstetrics
• Preventive Medicine

Background:

• Cardiovascular disease (CVD) is the primary cause of mortality in women globally.
• Effective cardiovascular risk assessment and primary prevention are crucial for reducing CVD morbidity and mortality.
• Traditional risk factors do not fully capture CVD risk in women, necessitating novel assessment approaches.

Purpose of the Study:

• To review current cardiovascular risk stratification schemes for women.
• To outline the role of obstetric history in refining cardiovascular risk assessment.
• To describe the utility of serum biomarkers in predicting cardiovascular outcomes.

Main Methods:

• Literature review of current cardiovascular risk stratification tools.
• Analysis of studies investigating the link between pregnancy complications and future CVD risk.
• Evaluation of research on serum biomarkers for cardiovascular risk assessment in women.

Main Results:

• Pregnancy complications like pre-eclampsia and gestational diabetes significantly increase future CVD risk.
• Serum biomarkers offer valuable insights for both risk assessment and outcome prediction in women.
• Integrating obstetric history and biomarker data can enhance the accuracy of risk stratification.

Conclusions:

• Current risk stratification models for women can be improved by incorporating obstetric history.
• Serum biomarkers play a vital role in identifying high-risk women and guiding preventive strategies.
• A comprehensive approach combining traditional factors, obstetric history, and biomarkers is essential for effective CVD prevention in women.